1. Home
  2. LMRI vs CERT Comparison

LMRI vs CERT Comparison

Compare LMRI & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lumexa Imaging Holdings Inc. Common Stock

LMRI

Lumexa Imaging Holdings Inc. Common Stock

HOLD

Current Price

$10.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Certara Inc.

CERT

Certara Inc.

HOLD

Current Price

$8.75

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMRI
CERT
Founded
2018
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
LMRI
CERT
Price
$10.70
$8.75
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$20.75
$11.67
AVG Volume (30 Days)
268.4K
1.9M
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.50
EPS
0.05
N/A
Revenue
N/A
$418,838,000.00
Revenue This Year
$6.35
$4.18
Revenue Next Year
$5.61
$5.39
P/E Ratio
$213.60
N/A
Revenue Growth
N/A
8.75
52 Week Low
$6.45
$4.45
52 Week High
$19.45
$13.88

Technical Indicators

Market Signals
Indicator
LMRI
CERT
Relative Strength Index (RSI) 36.96 59.66
Support Level $10.09 $8.54
Resistance Level $12.69 $8.89
Average True Range (ATR) 0.55 0.32
MACD -0.13 0.05
Stochastic Oscillator 0.57 96.31

Price Performance

Historical Comparison
LMRI
CERT

About LMRI Lumexa Imaging Holdings Inc. Common Stock

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: